This Week in Biotech
Motley Fool
Navidea drops after FDA nod for drug used in cancer patients
Fierce Biotech
Best And Worst FDA Drug Approval Stocks of 2013
TheStreet.com
Roche Leads Pack for Upcoming FDA Approvals
Motley Fool
Submitted by moderatorj on Tue, 11/13/2012 - 23:21
Navidea Biopharmaceuticals Announces PDUFA Goal Date for Lymphoseek® New Drug Application Resubmission
Yahoo/BusinessWire
Submitted by moderatorj on Thu, 11/08/2012 - 23:48
Navidea Biopharmaceuticals Announces Third Quarter 2012 Financial Results
Yahoo/BusinessWire
Submitted by moderatorj on Wed, 10/31/2012 - 22:56